Stella Diagnostics Inc (SLDX)

[Gentlemen Prefer Bonds]

Stella Diagnostics and Mayo Clinic presented data on the utility of the STLA101 Test for esophageal cancer staging at the 2022 American Gastroenterological Association Digestive Disease Week Conference in May. This is is the world's largest gathering of professionals in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Pictured below L to R are Mayo Clinic’s Dr Chris Hartley, Stella Diagnostics co-founder and board member Fred Zaino, and Dr Sumeet Mittal.